# Corvus Pharmaceuticals, Inc.: Form 8-K, filed Jul 22, 2026

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: 8-K
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 16:02 ET
- Period: 2026-07-21
- Accession: 0001104659-26-085790
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000110465926085790/crvs-20260721x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000110465926085790/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000110465926085790/crvs-20260721x8k.htm

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-085790. Last ingested by Listed: Nov 5, 2026, 16:49 ET. No prices; not investment advice.